Literature DB >> 20979493

Risk of postdischarge infection with vancomycin-resistant enterococcus after initial infection or colonization.

Rupak Datta1, Susan S Huang.   

Abstract

Postdischarge risks of vancomycin-resistant Enterococcus (VRE) infection among carriers are unknown. We conducted a retrospective cohort study of 199 patients newly detected as VRE carriers. Fifteen patients (8%) developed 27 VRE infections in the 18 months after detection. Among 10 postdischarge infections, 2 involved bacteremia and 3 resulted in readmission.

Entities:  

Mesh：

Year:  2010        PMID： 20979493      PMCID： PMC3075426          DOI： 10.1086/657332

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  7 in total

Review 1.  Insights into the epidemiology and control of infection with vancomycin-resistant enterococci.

Authors:  M K Hayden
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

2.  Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci.

Authors:  Aimee K Zaas; Xiaoyan Song; Pamela Tucker; Trish M Perl
Journal:  Clin Infect Dis       Date:  2002-10-17       Impact factor: 9.079

3.  Association between mucositis severity and vancomycin-resistant enterococcal bloodstream infection in hospitalized cancer patients.

Authors:  M J Kuehnert; J A Jernigan; A L Pullen; D Rimland; W R Jarvis
Journal:  Infect Control Hosp Epidemiol       Date:  1999-10       Impact factor: 3.254

4.  Duration of colonization with vancomycin-resistant Enterococcus.

Authors:  Karin E Byers; Anne M Anglim; Cynthia J Anneski; Barry M Farr
Journal:  Infect Control Hosp Epidemiol       Date:  2002-04       Impact factor: 3.254

5.  Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

Authors:  M B Edmond; J F Ober; D L Weinbaum; M A Pfaller; T Hwang; M D Sanford; R P Wenzel
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

6.  Natural history of colonization with vancomycin-resistant Enterococcus faecium.

Authors:  M A Montecalvo; H de Lencastre; M Carraher; C Gedris; M Chung; K VanHorn; G P Wormser
Journal:  Infect Control Hosp Epidemiol       Date:  1995-12       Impact factor: 3.254

Review 7.  Clinical impact of vancomycin-resistant enterococci.

Authors:  Robin Patel
Journal:  J Antimicrob Chemother       Date:  2003-06       Impact factor: 5.790
  7 in total
  3 in total

1.  Development of a Real-Time PCR Protocol Requiring Minimal Handling for Detection of Vancomycin-Resistant Enterococci with the Fully Automated BD Max System.

Authors:  Alexander H Dalpke; Marjeta Hofko; Stefan Zimmermann
Journal:  J Clin Microbiol       Date:  2016-06-29       Impact factor: 5.948

2.  Colonization with antibiotic-susceptible strains protects against methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition: a nested case-control study.

Authors:  Susan S Huang; Rupak Datta; Sheryl Rifas-Shiman; Ken Kleinman; Hilary Placzek; Julie D Lankiewicz; Richard Platt
Journal:  Crit Care       Date:  2011-09-14       Impact factor: 9.097

3.  Confounding by indication affects antimicrobial risk factors for methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition.

Authors:  Rupak Datta; Ken Kleinman; Sheryl Rifas-Shiman; Hilary Placzek; Julie Lankiewicz; Richard Platt; Susan S Huang
Journal:  Antimicrob Resist Infect Control       Date:  2014-06-01       Impact factor: 4.887
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.